TransCon CNP clinical trials

A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia

This study is for children and teenagers with achondroplasia who have already taken part in a trial for TransCon CNP. It aims to check the long-term safety and effects of this weekly medicine. Participants will continue treatment until their bones stop growing, with regular check-ups.